Travere Therapeutics, Inc. (TVTX)
29.16
-1.44
(-4.71%)
USD |
NASDAQ |
Feb 13, 14:16
Travere Therapeutics Free Cash Flow : -107.47M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 2.491B |
| Ligand Pharmaceuticals, Inc. | 20.43M |
| Plus Therapeutics, Inc. | -15.78M |
| BioStem Technologies, Inc. | 12.23M |
| Iovance Biotherapeutics, Inc. | -351.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 14.32M |
| Cash from Investing (Quarterly) | 86.59M |
| Cash from Financing (Quarterly) | -65.34M |
| Free Cash Flow Per Share (Quarterly) | -0.0085 |
| Free Cash Flow to Equity (Quarterly) | 68.95M |
| Free Cash Flow to Firm (Quarterly) | 1.879M |
| Free Cash Flow Yield | -4.06% |